| Literature DB >> 32117490 |
Qian Cheng Du1, Yan Yan Wang2, Chen Liang Hu3, Ying Zhou3.
Abstract
INTRODUCTION: The recurrence of cholecystolithiasis after choledochoscopic gallbladder-preserving surgery is a major problem. It is unclear whether the recurrence of cholecystolithiasis is due to the limitations of the operation itself or to the selection of inappropriate candidates. AIM: To analyze the recurrence of cholecystolithiasis after choledochoscopic gallbladder-preserving surgery and to provide guidance for the treatment of cholecystolithiasis by choledochoscopic gallbladder-preserving surgery.Entities:
Keywords: cholecystolithiasis; gallbladder preservation; recurrence; risk factors
Year: 2019 PMID: 32117490 PMCID: PMC7020701 DOI: 10.5114/wiitm.2019.88647
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.195
Photo 1Surgery photographs. A – The gallbladder stone was clearly seen after the bile was suctioned out, B – the gallstones were removed from the gallbladder using a grasping basket guided by the soft fiber choledochoscope, C – the bile was observed to flow from the neck of the gallbladder into the fundus of the gallbladder, D – using stitches the fundus of gallbladder was sutured continuously
Baseline characteristics of the included patients after gallbladder-preserving cholecystolithotomy
| Variable | Total | Recurrence | |
|---|---|---|---|
| Yes | No | ||
| Age [years]: | 36.60 ±11.57 | ||
| > 40 | 67 (46.2%) | 7 | 60 |
| ≤ 40 | 78 (53.8%) | 7 | 71 |
| Sex: | |||
| Female | 92 (63.4%) | 10 | 82 |
| Male | 53 (36.6%) | 4 | 49 |
| BMI [kg/m2]: | 23.16 ±3.54 | ||
| > 28 | 14 (9.7%) | 3 | 11 |
| ≤ 28 | 131 (90.3%) | 13 | 118 |
| Pregnancy history (N): | |||
| ≥ 2 | 56 (68.3%) | 7 | 59 |
| ≤ 1 | 26 (31.7%) | 3 | 23 |
| Family history: | |||
| Present | 26 (17.9%) | 5 | 21 |
| Absent | 119 (82.1%) | 9 | 110 |
| Lifestyle: | |||
| Free | 40 (27.6%) | 9 | 31 |
| Regular | 105 (72.4%) | 5 | 100 |
| Preoperative symptoms: | |||
| Present | 120 (82.8%) | 13 | 107 |
| Absent | 25 (17.2%) | 1 | 24 |
| Number of gallstones: | |||
| < 3 | 104 (71.7%) | 7 | 97 |
| ≥ 3 | 41 (28.3%) | 7 | 34 |
| Maximal diameter of gallstones: | |||
| < 2 cm | 92 (63.4%) | 6 | 86 |
| ≥ 2 cm | 53 (36.6%) | 8 | 45 |
| Shape of gallstones: | |||
| Uniform | 96 (66.2%) | 4 | 92 |
| Non-uniform | 49 (33.8%) | 10 | 39 |
| Gallbladder wall: | |||
| Normal | 105 (72.4%) | 12 | 93 |
| Thickening | 40 (27.6%) | 2 | 38 |
| Gallbladder mucosa: | |||
| Smooth | 112 (77.2%) | 11 | 101 |
| Rough | 33 (22.8%) | 3 | 30 |
| Gallbladder contraction function: | |||
| < 30% | 30 (20.7%) | 4 | 26 |
| ≥ 30% | 115 (79.3%) | 10 | 105 |
| Preoperative inflammation: | |||
| Present | 44 (30.3%) | 8 | 36 |
| Absent | 101 (69.7%) | 6 | 95 |
| White blood cells [×109/l] | 5.96 (3.00–10.93) | 6.67 (4.63–9.61) | 5.93 (3.00–10.93) |
| Neutrophil ratio (%) | 56.70 (36.20–80.90) | 56.62 (48.20–77.30) | 56.70 (36.20–80.90) |
| Preoperative ALT [U/l] | 26 (9–376) | 21 (10–114) | 26 (9–376) |
| Preoperative AST [U/l] | 24 (13–188) | 21.50 (13–56) | 25 (13–188) |
| Postoperative ALT [U/l] | 23 (12–117) | 19 (16–117) | 23 (12–78) |
| Postoperative AST [U/l] | 25 (15–77) | 26 (19–43) | 25 (15–77) |
| Preoperative TCH [mmol/l] | 3.94 (1.18–7.37) | 3.66 (2.53–5.34) | 4.06 (1.18–7.37) |
| Preoperative TG [mmol/l] | 1.41 (0.37–4.73) | 1.29 (0.67–2.48) | 1.44 (0.37–4.73) |
| Preoperative HDL [mmol/l] | 1.07 (0.60–2.13) | 1.05 (0.84–1.26) | 1.08 (0.60–2.13) |
| Preoperative LDL [mmol/l] | 2.30 (1.02–4.36) | 2.07 (1.20–3.04) | 2.32 (1.02–4.36) |
| Preoperative APOA [g/l] | 1.11 (0.60–2.01) | 1.11 (0.80–1.43) | 1.11 (0.60–2.01) |
| Preoperative APOB [g/l] | 0.74 (0.26–1.91) | 0.80 (0.26–1.91) | 0.74 (0.36–1.23) |
TG – triglyceride, TCH – total cholesterol, BMI – body mass index, ALT – alanine transaminase, AST – aspartate amino transferase, HDL – high-density lipoprotein, LDH – low-density lipoprotein, APOA – apolipoprotein A, APOB – apolipoprotein B.
Figure 1Kaplan-Meier survival curve of the estimated recurrence rate of 145 patients after choledochoscopic gallbladder-preserving surgery
Univariate analysis of possible clinical factors for recurrence
| Variable | |
|---|---|
| Age (< 40/≥ 40) | 0.765 |
| Sex (male/female) | 0.514 |
| BMI (< 28/≥ 28 kg/m2) | 0.192 |
| Preoperative symptoms (yes/no) | 0.293 |
| Pregnancy history (≤ 1/≥ 2) | 0.008 |
| Preoperative TCH (< 5.17/≥ 5.17 mmol/l) | 0.529 |
| Preoperative TG (< 1.7/≥ 1.7 mmol/l) | 0.803 |
| Number of gallstones (< 3/≥ 3) | 0.058 |
| Maximal diameter of gallstones (< 2/≥ 2 cm) | 0.092 |
| Gallbladder wall (normal/thickening) | 0.241 |
| Gallbladder mucosa (smooth/rough) | 0.901 |
| Gallbladder contraction function (< 30%/≥ 30%) | 0.444 |
| Uniformity of gallstones (uniform/nonuniform) | 0.002 |
| Preoperative inflammation (present/absent) | 0.022 |
| Postoperative oral medication (yes/no) | 0.022 |
| Regularity of diet (regular/irregular) | 0.001 |
| Family history (present/absent) | 0.068 |
| Smoker (yes/no) | 0.127 |
| Long-time drinking (yes/no) | 0.275 |
TG – triglyceride, TCH – total cholesterol, BMI – body mass index.
Results of multivariate analyses for recurrence after gallbladder-preserving cholecystolithotomy
| Variable | OR | 95% CI | |
|---|---|---|---|
| Pregnancy history (≤ 1/≥ 2) | 0.190 | 0.030–1.197 | 0.077 |
| Uniformity of gallstones (uniform/non-uniform) | 0.079 | 0.010–0.590 | 0.013 |
| Preoperative inflammation (present/absent) | 1.088 | 0.160–7.397 | 0.931 |
| Postoperative oral medication (yes/no) | 2.840 | 0.417–19.353 | 0.286 |
| Regularity of diet (regular/irregular) | 0.074 | 0.010–0.528 | 0.009 |
OR – odds ratio, CI – confidence interval.
Figure 2Kaplan-Meier analysis of the recurrence rate of patients with uniform gallstones versus nonuniform gallstones (A), regular lifestyle versus irregular lifestyle (B)
Figure 3Number of patients with different independent risk factors